(0.07%) 5 521.00 points
(0.11%) 39 887 points
(0.16%) 19 782 points
(0.01%) $81.64
(0.50%) $2.83
(-0.33%) $2 336.70
(-0.03%) $29.52
(0.30%) $1 004.80
(0.01%) $0.932
(0.01%) $10.54
(-0.01%) $0.788
(-0.57%) $87.50
1.27% $ 5.60
Live Chart Being Loaded With Signals
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms...
Stats | |
---|---|
Dzisiejszy wolumen | 187 990 |
Średni wolumen | 680 050 |
Kapitalizacja rynkowa | 137.16M |
EPS | $-2.43 ( Q1 | 2024-03-31 ) |
Następna data zysków | ( $-0.0600 ) 2024-08-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-5.02 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00500 (0.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-11-16 | Kay Mark A | Sell | 12 500 | Stock Option (right to buy) |
2022-11-16 | Enyedy Mark J | Sell | 12 500 | Stock Option (right to buy) |
2022-11-16 | Nacht Mariana | Sell | 100 000 | Stock Option (right to buy) |
2022-11-16 | Wyzga Michael S | Sell | 12 500 | Stock Option (right to buy) |
2022-11-16 | Chereau Frederic | Sell | 328 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
-97.51 |
Last 94 transactions |
Buy: 5 628 346 | Sell: 1 216 285 |
Wolumen Korelacja
LogicBio Therapeutics, Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
LogicBio Therapeutics, Korelacja - Waluta/Towar
LogicBio Therapeutics, Finanse
Annual | 2023 |
Przychody: | $287.00M |
Zysk brutto: | $59.00M (20.56 %) |
EPS: | $-13.36 |
FY | 2023 |
Przychody: | $287.00M |
Zysk brutto: | $59.00M (20.56 %) |
EPS: | $-13.36 |
FY | 2021 |
Przychody: | $5.41M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.240 |
FY | 2020 |
Przychody: | $3.45M |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.290 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
LogicBio Therapeutics,
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company\'s GeneRide technology is a new approach to precise gene insertion harnessing a cell\'s natural deoxyribonucleic acid; and gene delivery platform, sAAVy is an adeno-associated virus, which is designed to optimize gene delivery for treatments in a range of indications and tissues. Its lead product candidate is LB-001 that is in Phase I/II clinical trials for the treatment of methylmalonic acidemia. The company has a collaboration with Children\'s Medical Research Institute to develop next-generation capsids for gene therapy and gene editing applications in the liver, as well as additional tissues; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop LB-301, an investigational therapy for the treatment of Crigler-Najjar syndrome. The company also has a research collaboration, license, and option agreement with CANbridge Care Pharma Hong Kong Limited; and collaboration agreement with Daiichi Sankyo Company. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts. As of November 15, 2022, LogicBio Therapeutics, Inc. operates as a subsidiary of Alexion Pharmaceuticals, Inc..
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej